Yin Lina,Zhang Xuxia,Wang Jing,Zhang Yaping,Bao Yizhong,Zhang Junxiang,Chen Honghong.Radiosensitization of human triple-negative breast cancer MDA-MB-231 cells by antihelminthic niclosamide[J].Chinese Journal of Radiological Medicine and Protection,2014,34(4):244-249
Radiosensitization of human triple-negative breast cancer MDA-MB-231 cells by antihelminthic niclosamide
Received:August 27, 2013  
DOI:10.3760/cma.j.issn.0254-5098.2014.04.002
KeyWords:Niclosamide  Radiosensitization  β-catenin  MDA-MB-231 cells
FundProject:上海市自然科学基金(13ZR1403500)
Author NameAffiliationE-mail
Yin Lina Department of Radiation Biology, Institute of Radiation Medicine, Fudan University, Shanghai 200032, China  
Zhang Xuxia Department of Radiation Biology, Institute of Radiation Medicine, Fudan University, Shanghai 200032, China  
Wang Jing Department of Radiation Biology, Institute of Radiation Medicine, Fudan University, Shanghai 200032, China  
Zhang Yaping Department of Radiation Biology, Institute of Radiation Medicine, Fudan University, Shanghai 200032, China  
Bao Yizhong Department of Radiation Biology, Institute of Radiation Medicine, Fudan University, Shanghai 200032, China  
Zhang Junxiang Department of Radiation Biology, Institute of Radiation Medicine, Fudan University, Shanghai 200032, China  
Chen Honghong Department of Radiation Biology, Institute of Radiation Medicine, Fudan University, Shanghai 200032, China hhchen@shmu.edu.cn 
Hits: 3386
Download times: 2296
Abstract::
      Objective To investigate the radiosensitization effect of antihelminthic niclosamide on human triple-negative breast cancer MDA-MB-231 cells and the potential mechanism related to Wnt/β-catenin signaling pathway. Methods Four methyl thiazolyl tetrazolium(MTT)assay was used to measure the effect of niclosamide on cell viability at different concentrations and 50% inhibitory concentration(IC50)value was calculated. MDA-MB-231 cells were divided into 4 groups: untreated control, niclosamide treatment alone group, radiation alone group and niclosamide plus radiation treatment group. The cells with or without 1.0 and 1.5 μmol/L niclosamide pre-treatment were irradiated with 137Cs γ-rays at doses of 0, 2, 4 and 6 Gy. Cell survival was assayed with the colony formation method, radiation-induced γH2AX foci was analyzed with immunofluorescence, cell cycle progression was assayed with flow cytometry, and the changes of phospho-and non-phospho-β-catenin and Cyclin D1 protein expressions were measured with Western blot. Results Niclosamde obviously inhibited the viability of MDA-MB-231 cells in a dose-dependent manner with a IC50 value of 13.63 μmol/L. Pretreatment of cells with 1.0 and 1.5 μmol/L niclosamide evidently enhanced the radiosensitivity of MDA-MB-231 cells to γ-rays, and the values of SER were 1.37 and 1.62, respectively. Niclosamide pretreatment significantly increased radiation-induced γH2AX foci formation(t=3.91, P<0.05), diminished the radiation-induced G2/M arrest(t=8.05, P<0.01), and inhibited radiation-induced expressions of phospho-β-catenin (S675),non-phospho-β-catenin and Cyclin D1 proteins in MDA-MB-231 cells. Conclusions Niclosamide significantly can enhance the sensitivity of MDA-MB-231 cells to γ-ray irradiation through inhibiting Wnt/β-catenin signaling pathway, which results in the inhibition of DNA DSBs repair and the reduction of radiation-induced G2/M arrest. Wnt/β-catenin signaling pathway may serve as an ideal molecular target for radiosensitization of triple-negative breast cancer.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9061100  On-line:0

v
Scan QR Code
&et=127E40F7BD15B54261E623AF7B0778C8E9132B7EC44D4CD4AC2F81EA9771860E54AA4AF33F1ADB3A4D46FC736BE51582F96E53CE4282110E8324B133C7C4F5BB0964AA062B20C774CD949290EAC3156BB8828A7A40B3EF30DD81F203794E093E8716AF1003FE3F51E757F09376F2A77C&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=9EAD63ADE6B277ED&aid=6254F803FD8F634359D5F23B0D449689&vid=&iid=E158A972A605785F&sid=5B5B75F4854B8331&eid=D537C66B6404FE57&fileno=20140402&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="9EAD63ADE6B277ED"; var my_aid="6254F803FD8F634359D5F23B0D449689";